Our company name — Hanwha Impact — encapsulates our vision of "creating a positive impact on people and the planet through technological innovation that leads to a sustainable future." As an investment company, we are embarking on a new journey focused on developing eco-friendly energy solutions and fostering future innovative technologies that will help us achieve our goal of creating a sustainable planet.
Hanwha Impact seeks to create a future in which humans and nature, reality and the virtual world all coexist, supported by innovative convergent technologies in several sectors, including the energy transition, life sciences, and digital and data technologies. Along with eco-friendly energy and purified terephthalic acid (PTA) businesses, we secure sustainable technologies with business development and open innovation based on active M&A and strategic investments. We are strengthening our competitiveness by preemptively investing in technologies and companies that will have a positive impact on humanity and the world. As one green solution, we’re making hydrogen-focused investments to accelerate the transition to a carbon-neutral society.
In 2021, we successfully localized hydrogen gas turbine technology by acquiring the U.S.-based PSM and Netherlands-based Thomassen Energy. In April 2023, we succeeded in demonstrating the world’s first 60% hydrogen co-firing power generation in an 80 megawatt-class gas turbine. In November 2023, we demonstrated hydrogen fuel-based power generation, taking us a step closer to commercializing carbon-free, low-emission power generation. Moving forward, we will continue to invest in eco-friendly hydrogen power generation businesses. As to investing in future innovation technologies, we are exploring promising businesses that create disruptive innovations across diverse industries by applying and converging technologies in fields such as genetic engineering, biotechnology, data storage and utilization, and the bio industry. Our key investments currently include Inari Agriculture, a plant breeding technology company with gene editing technology; Catalog Technology, a DNA-based data storage solutions provider; and Tessera Therapeutics, a genome engineering technology company.
Hanwha’s PTA business is a continuous profit center for the company. PTA was developed as a base material for polyester to replace natural cotton. It is now used as the primary component in many types of polyester owing to its superior resistance to heat, mechanical strength, water resistance, wear resistance, and insulation compared to other products. The applications for PTA are expanding into uses other than clothing, such as PET resin, film, paint, and industrial fibers. We will further strengthen our competitiveness by improving our PTA-related technologies and continuing to develop related businesses in the value chain.
Supported by our professional investment system and talent, we will expand investments in innovative technologies, businesses and companies that have a positive impact on humanity and the planet. We will create a sustainable future by developing technologies that accelerate the transition to a carbon neutral and eco-friendly energy society as we invest in forward-looking convergence technologies, such as biotechnology, AI, and next-generation computing.
Get the latest news about Hanwha, right in your inbox.
Fields marked with * are mandatory.